Monday, January 9, 2023

SEMA4 Changes Name and NASDAQ Ticker to "GeneDx", "WGS"

Sema4 announces on January 9, 2023, it is changing its name to GeneDx and getting a new NASDAQ ticker as WGS (aka whole genome sequencing).

https://ir.genedx.com/news-releases/news-release-details/sema4-announces-name-change-genedx-and-provides-preliminary-2022

GemeDx was the longstanding name of the genetics lab division of Bioreference (itself part of OPKO).  GeneDx was acquired by Sema4 in January 2022 for $623M per Fierce Biotech.   Sema4 has had a difficult stock price ride, from $20 to 30 cents in about 24 months.  

See open access story at Genomeweb.